1 – 24 of 24
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men
(
- Contribution to journal › Article
- 2014
-
Mark
Plasma alkylresorcinol metabolites as biomarkers for whole-grain intake and their association with prostate cancer: a Swedish nested case-control study.
(
- Contribution to journal › Article
- 2012
-
Mark
Measures of birth size in relation to risk of prostate cancer: the Malmo Diet and Cancer Study, Sweden
(
- Contribution to journal › Article
- 2011
-
Mark
Food sources of fat and sex hormone receptor status of invasive breast tumors in women of the malmö diet and cancer cohort.
(
- Contribution to journal › Article
- 2010
-
Mark
Plasma Folate Concentrations Are Positively Associated with Risk of Estrogen Receptor {beta} Negative Breast Cancer in a Swedish Nested Case Control Study.
(
- Contribution to journal › Article
- 2009
-
Mark
The Protective Association of High Plasma Enterolactone with Breast Cancer Is Reasonably Robust in Women with Polymorphisms in the Estrogen Receptor alpha and beta Genes
(
- Contribution to journal › Article
-
Mark
Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele.
(
- Contribution to journal › Article
-
Mark
A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk.
(
- Contribution to journal › Article
-
Mark
Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
(
- Contribution to journal › Article
- 2008
-
Mark
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study
(
- Contribution to journal › Article
-
Mark
Do both heterocyclic amines and omega-6 polyunsaturated fatty acids contribute to the incidence of breast cancer in postmenopausal women of the Malmö diet and cancer cohort?
(
- Contribution to journal › Article
-
Mark
Plant foods and estrogen receptor {alpha} and {beta} defined breast cancer: observations from the Malmo Diet and Cancer cohort.
(
- Contribution to journal › Article
- 2007
-
Mark
A prospective study on dietary fat and incidence of prostate cancer (Malmö, Sweden).
(
- Contribution to journal › Article
-
Mark
High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort
(
- Contribution to journal › Article
-
Mark
High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmö Diet and Cancer cohort
(
- Contribution to journal › Article
- 2005
-
Mark
Fat from different foods show diverging relations with breast cancer risk in postmenopausal women.
(
- Contribution to journal › Article
- 2004
-
Mark
Birth weight is associated with postmenopausal breast cancer risk in Swedish women
(
- Contribution to journal › Article
-
Mark
Intakes of plant foods, fibre and fat and risk of breast cancer - a prospective study in the Malmö Diet and Cancer cohort.
(
- Contribution to journal › Article
-
Mark
No relations between breast cancer risk and fatty acids of erythrocyte membranes in postmenopausal women of the Malmo Diet Cancer cohort (Sweden)
(
- Contribution to journal › Article
-
Mark
High fat and alcohol intakes are risk factors of postmenopausal breast cancer: A prospective study from the Malmö diet and cancer cohort.
(
- Contribution to journal › Article
- 2003
-
Mark
A prospective study of adiposity and postmenopausal breast cancer risk: The Malmö diet and cancer study.
(
- Contribution to journal › Article
- 2002
-
Mark
Postmenopausal breast cancer is associated with high intakes of omega6 fatty acids (Sweden).
(
- Contribution to journal › Article
- 1990
-
Mark
Increased plasma prolactin levels in a group of men with breast cancer - a preliminary study
(
- Contribution to journal › Article
- 1983
-
Mark
Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease
(
- Contribution to journal › Article